0001209191-21-043205.txt : 20210625
0001209191-21-043205.hdr.sgml : 20210625
20210625075807
ACCESSION NUMBER: 0001209191-21-043205
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210624
FILED AS OF DATE: 20210625
DATE AS OF CHANGE: 20210625
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Bolte Axel
CENTRAL INDEX KEY: 0001579247
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39397
FILM NUMBER: 211044731
MAIL ADDRESS:
STREET 1: PTC THERAPEUTICS, INC.
STREET 2: 100 CORPORATE COURT
CITY: SOUTH PLAINFIELD
STATE: NJ
ZIP: 07080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Inozyme Pharma, Inc.
CENTRAL INDEX KEY: 0001693011
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 475129768
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 321 SUMMER STREET
STREET 2: SUITE 400
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: 857-330-4340
MAIL ADDRESS:
STREET 1: 321 SUMMER STREET
STREET 2: SUITE 400
CITY: BOSTON
STATE: MA
ZIP: 02210
FORMER COMPANY:
FORMER CONFORMED NAME: Inozyme Pharma, LLC
DATE OF NAME CHANGE: 20161222
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-06-24
0
0001693011
Inozyme Pharma, Inc.
INZY
0001579247
Bolte Axel
C/O INOZYME PHARMA, INC.
321 SUMMER STREET SUITE 400
BOSTON
MA
02210
1
1
0
0
Chief Executive Officer
Common Stock
2021-06-24
4
M
0
66788
0.98
A
257613
D
Common Stock
2021-06-24
4
S
0
66788
0.0001
D
190825
D
Stock Option (right to buy)
0.98
2021-06-24
4
M
0
66788
0.00
D
2027-06-27
Common Stock
66788
100480
D
Represents a transfer by Reporting Person to HBM Partners AG in satisfaction of Reporting Person's obligation pursuant to a prior agreement with Reporting Person's former employer.
These options are fully vested.
/s/ Axel Bolte
2021-06-25